A Wild Swinger, a Solar Shake-Up, and a Tariff Speed Bump in Med Tech

Three very different stories, one common mistake: chasing the first move. One stock is ripping with more motion than explanation, one solar name just cleared a legal cloud while quietly reloading the tank, and one med-tech heavyweight beat the quarter but slipped in a 2026 curveball. The setups are cleaner than the headlines, and the tells are surprisingly simple.

IQST Is Building Global Telecom + AI Infrastructure

IQSTEL Inc. (IQST) operates a global connectivity platform spanning telecom, AI, fintech, and cybersecurity.

The company does business across 20+ countries, supports hundreds of carrier connections worldwide, and already generates real revenue.

With a clean balance sheet and an aggressive long-term roadmap, management is positioning IQST as a next-generation digital infrastructure play.

Click here to review the full IQST company overview and growth strategy.

*Paid advertisement for investor awareness. Elite Trade Media LLC received $15,000 from a third party for promotional services related to IQST from 1/22/26 to 1/29/26. Elite Trade Media LLC is not a registered investment adviser or broker. This is not investment advice or a solicitation to buy or sell securities. Investing in microcap and low-priced securities involves significant risk, including loss of capital, volatility, illiquidity, and dilution. Readers should conduct their own research and consult a licensed financial professional. Past performance is not indicative of future results.

Futures are a little wobbly this morning after two straight rebound days, with traders still riding the relief wave from eased tariff and Greenland headline pressure. The feeling is cautious, though, especially after Intel face-planted after hours on a soft outlook. Oil’s creeping up while yields ease, which basically screams risk is back… so keep your helmet on.

Elite Trade Club now offers text alerts — so you get trending stocks and market-moving news sent straight to your phone before the bell.

Email’s great. Texts are faster.

👉 Click here to get our pre-market report to your cell for free!

You’ll be first in line when the market starts moving.

Earnings (Premarket):

Economic Reports:

Regencell Bioscience Holdings Ltd (NASDAQ: RGC) ripped higher again, and the funniest part is the plot did not even change. No splashy update, no fresh filing, no new “here’s what we’re building” moment. Just the stock doing gymnastics because it felt like it. That is not investing, that is cardio.

This thing has been moving like a shopping cart with one bad wheel. One day it veers hard left, the next day it rockets down the aisle, and you are standing there wondering how you ended up in frozen foods. When a name swings this wide without new info, the only real catalyst is other traders staring at the same candle and deciding to pile in.

Also, wide moves tend to invite the volatility halts, which is the market’s way of saying everyone take a breath before someone trips. That can be great if you are already positioned and awful if you are chasing.

My Take For You: If you are not in, do not chase the pop. Wait for it to cool, then only nibble with strict rules. If you are in, consider skimming some gains and trailing a tight exit.

My Verdict: Pure momentum toy. Trade it small, trade it fast, and do not confuse excitement with edge.

Canadian Solar Inc (NASDAQ: CSIQ) scored a patent win, which is basically the company clearing a nasty speed bump off the road. That matters because legal overhangs can spook buyers and slow down deals, especially when everyone is already paranoid about pricing pressure in solar.

But then the company followed up with a notes offering, and that is where the vibe shifts from “nice win” to “okay, what’s the plan.” Raising money is not automatically bad. Sometimes it is smart insurance. Sometimes it is a hint the next phase needs fuel. Either way, it often triggers the same market reflex: dilution fears, execution questions, and traders doing math on future cash flows while pretending they are not.

So this story is not just a legal headline. It is a credibility test. Can they turn scale into cleaner profitability, and can they use fresh financing without leaving shareholders holding the bag?

My Take For You: If you are new, let the market digest the notes and look for a calmer entry. If you own it, trim into strength and re-add only if it holds key levels and news stays constructive.

My Verdict: Watch-list with real catalysts, but it is still a patience trade, not a chase trade.

$1,000 in just seven stocks in 2004 could have turned into a million-dollar portfolio today…

Back then… one financial expert begged people to look at Nvidia -- when it was trading at just $1.10!

Now… he’s urging you to look at a new group of seven stocks…

Check this Out (The NEXT Magnificent Seven)  

Intuitive Surgical Inc (NASDAQ: ISRG) delivered a solid quarter, and the stock still did that after-hours wiggle like it just read the fine print. That is the curse of a premium name: good results are expected, and the forward-looking vibe is what moves the price.

Here is the simple way to think about it. This business runs on procedure volume and stickiness. Hospitals buy the system, then keep buying the tools, accessories, and service. That recurring stream is the real engine. So when the company talks about procedure growth slowing even a bit, the market listens like it is a spoiler.

Now toss in tariff worries and margin pressure, and you get a stock that can feel jittery even when the core story is still strong. It is not that the business broke. It is that expectations are wearing skinny jeans and there is no room for surprises.

My Take For You: If you are not in, let it settle for a day or two and look for a cleaner setup. If you are in, consider trimming a little into strength and keeping the rest with a clear line in the sand.

My Verdict: High-quality long-term name, but short-term it can punish impatience. Let the chart calm down before you add.

Korea’s delivery machine is getting the value-hunter treatment after a rough stretch. The stock’s been slumping, and now the internet is doing that thing where it squints at spreadsheets and says maybe this is cheap.

The catch is this name loves to make you wait. Coupang will spend to grow, and the market will spend the next month arguing with itself about whether that’s smart or just expensive cardio.

The railroad just did the classic beat-the-quarter, shrug-at-the-demand combo. Earnings came in a touch better, revenue a touch lighter, and the stock still popped because Wall Street loves a good cost-control glow-up.

This is a freight business, so it’s basically the economy with wheels. When industrial demand is sleepy, the trick is keeping the train on time and the expense line on a diet.

Intel just went from hero to whoops overnight. After a monster run, the forecast hit the market like a cold shower, and the stock is paying the price before breakfast.

The demand is there, but supply is tight, and the Street hates any sentence that sounds like we cannot ship enough stuff right now.

Political transitions historically increase uncertainty—and this cycle is no exception.

Tariff expansion is reviving crash-risk conversations across Wall Street.

Asset protection strategies are gaining attention as volatility accelerates.

Ignoring structural risk has consequences during regime shifts.

Awareness precedes action.

No guarantees are implied.

This content is not a recommendation to buy or sell.

Download the FREE Presidential Transition Guide now.

That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.

Best Regards,

— Adam Garcia
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.